Sharenet Sites 
Sharenet Sites
No Change Statement And Notice Of Annual General Meeting – 7 December 2017
ASPEN PHARMACARE HOLDINGS LIMITED
(Incorporated in the Republic of South Africa)
Registration number 1985/0002935/06
Share code: APN
ISIN: ZAE000066692
("Aspen Holdings" or "the Company")
NO CHANGE STATEMENT AND NOTICE OF ANNUAL GENERAL MEETING –
7 DECEMBER 2017
1. POSTING OF INTEGRATED REPORT AND AGM NOTICE
Shareholders are advised that the Company’s Integrated Report for the year ended 30 June 2017 has
been finalised and that this report and the notice of the annual general meeting (“AGM”) to be held
at its Durban offices on 7 December 2017 is being posted to shareholders. The Integrated Report,
notice of AGM and the following documents are also available online at the Company’s website
www.aspenpharma.com at the following link - http://www.aspenpharma.com/results-and-reports/:
- Unabridged Corporate Governance Statement and reports of the Aspen Audit & Risk and
Social & Ethics committees for the 2017 financial year; and
- the Annual Financial Statements for the 2017 financial year (“AFS”).
The AFS contain no modifications to the reviewed provisional results which were published on
SENS on 14 September 2017. The AFS were audited by PricewaterhouseCoopers Inc. Their
unqualified report, along with an originally signed copy of the AFS, is available for inspection at
the Company’s registered office.
2. NOTICE OF AGM
Notice is hereby given that the 19th annual general meeting of the shareholders of the Company will
be held at Aspen Place, 9 Rydall Vale Park, Douglas Saunders Drive, La Lucia Ridge Office Park,
Durban, Kwa-Zulu Natal, on Thursday, 7 December 2017 at 10:00.
The record date on which a person must be registered as a shareholder in the register of the
Company for purposes of being entitled to attend and participate in, and speak and vote at, the
meeting is Friday, 1 December 2017. Accordingly, the last day to trade in order to be registered in the
register of members of the Company and therefore be eligible to participate in and vote at the annual
general meeting is Tuesday, 28 November 2017. Shareholders are requested, but are not obliged,
to submit their completed forms of proxy to the Company’s transfer secretaries (Terbium Financial
Services) before 10:00 on Monday, 4 December 2017.
Shareholders who, for whatever reason, experience postal delays and who do not receive the
notice of the AGM in time to submit proxy forms to the Company’s share transfer secretaries
(Terbium Financial Services) are requested to access the notice of AGM and other documents
referred to above on the Company’s website www.aspenpharma.com. A printable version of these
documents in PDF format can also be emailed to shareholders upon request to the Company
Secretary – rverster@aspenpharma.com or +27 31 580 8624.
3. BROAD-BASED BLACK ECONOMIC EMPOWERMENT CERTIFICATE
Shareholders are hereby notified that in accordance with the JSE Listings Requirements, the
Company's B-BBEE compliance report in terms of section 13G(2) of the Broad-Based Black
Economic Empowerment Act 53 of 2003 read with the Broad-Based Black Economic
Empowerment Act 46 of 2013, has been submitted to the BEE Commission and is available on the
Company’s website www.aspenpharma.com.
Durban
31 October 2017
Sponsor
Investec Bank Limited
Date: 31/10/2017 12:30:00 Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE').
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct,
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
information disseminated through SENS.
